A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy
Clinical trial NCT03270176 · COMPLETED
Trial details
- NCT number
- NCT03270176
- Sponsor
- Debiopharm International SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2022-03-22
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.